Cargando…

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

To improve the understanding of the complex biological processes underlying the development of non-alcoholic steatohepatitis (NASH), a multi-omics approach combining bulk RNA-sequencing based transcriptomics, quantitative proteomics and single-cell RNA-sequencing was used to characterize tissue biop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ægidius, Helene M., Veidal, Sanne S., Feigh, Michael, Hallenborg, Philip, Puglia, Michele, Pers, Tune H., Vrang, Niels, Jelsing, Jacob, Kornum, Birgitte R., Blagoev, Blagoy, Rigbolt, Kristoffer T. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981216/ https://www.ncbi.nlm.nih.gov/pubmed/31980690 http://dx.doi.org/10.1038/s41598-020-58059-7

Ejemplares similares

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
por: Roth, Jonathan D, et al.
Publicado: (2018)

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
por: Hansen, Henrik H., et al.
Publicado: (2020)

Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis
por: Tølbøl, Kirstine S., et al.
Publicado: (2018)

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
por: Boland, Michelle L, et al.
Publicado: (2019)

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
por: Baandrup Kristiansen, Maria Nicoline, et al.
Publicado: (2019)

Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease
por: Sembach, Frederikke E., et al.
Publicado: (2021)

Phosphoproteomic profiling reveals a defined genetic program for osteoblastic lineage commitment of human bone marrow–derived stromal stem cells
por: Barrio-Hernandez, Inigo, et al.
Publicado: (2020)

Phosphorylation Site Dynamics of Early T-cell Receptor Signaling
por: Chylek, Lily A., et al.
Publicado: (2014)

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH
por: Møllerhøj, Mathias B., et al.
Publicado: (2022)

Molecular consequences of peripheral Influenza A infection on cell populations in the murine hypothalamus
por: Lemcke, René, et al.
Publicado: (2023)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Madsen, Mette Simone Aae, et al.
Publicado: (2019)

The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
por: Perakakis, Nikolaos, et al.
Publicado: (2020)

Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss
por: Barkholt, Pernille, et al.
Publicado: (2019)

Whole-brain activation signatures of weight-lowering drugs
por: Hansen, Henrik H., et al.
Publicado: (2021)

Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis
por: Fred, Rikard G., et al.
Publicado: (2022)

Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression
por: Støy, Sidsel, et al.
Publicado: (2020)

The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice
por: Cucak, Helena, et al.
Publicado: (2016)

Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
por: Nestor, John J., et al.
Publicado: (2022)

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
por: Dalbøge, Louise S., et al.
Publicado: (2015)

Complex Times, Complex Time: The Pandemic, Time‐Based Theorizing and Temporal Research in Management and Organization Studies
por: Kunisch, Sven, et al.
Publicado: (2021)

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity
por: Hagemann, Christoffer A., et al.
Publicado: (2022)

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
por: Barkholt, Pernille, et al.
Publicado: (2016)

Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes
por: Osinalde, Nerea, et al.
Publicado: (2016)

Data on interleukin (IL)-2- and IL-15-dependent changes in IL-2Rβ and IL-2Rγ complexes
por: Osinalde, Nerea, et al.
Publicado: (2017)

Pre-treatment of blood samples reveal normal blood hypocretin/orexin signal in narcolepsy type 1
por: Ægidius, Helene M, et al.
Publicado: (2021)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Identification of ester-linked ubiquitylation sites during TLR7 signalling increases the number of inter-ubiquitin linkages from 8 to 12
por: McCrory, Elisha H., et al.
Publicado: (2022)

Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats
por: Hansen, Carl Frederik, et al.
Publicado: (2013)

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II
por: Roostalu, Urmas, et al.
Publicado: (2020)

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
por: Hansen, Henrik H., et al.
Publicado: (2021)

SILAC-based quantification of changes in protein tyrosine phosphorylation induced by Interleukin-2 (IL-2) and IL-15 in T-lymphocytes
por: Osinalde, Nerea, et al.
Publicado: (2015)

Data on mass spectrometry-based proteomics for studying the involvement of CYLD in the ubiquitination events downstream of EGFR activation
por: Sanchez-Quiles, Virginia, et al.
Publicado: (2018)

SPANX-A/D protein subfamily plays a key role in nuclear organisation, metabolism and flagellar motility of human spermatozoa
por: Urizar-Arenaza, Itziar, et al.
Publicado: (2020)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_quo1ntqsrgopm9ripfln6v4bi3